Influenza vaccination and major adverse vascular events in high-risk patients

Circulation

Volumn 126, Issue 3, 2012, Pages 278-286

  Johnstone, Jennie ^a   Loeb, Mark ^a   Teo, Koon K ^a,b   Gao, Peggy ^b   Dyal, Leanne ^b   Liu, Lisheng ^c   Avezum, Alvaro ^d   Cardona Munoz, Ernesto ^e   Sleight, Peter ^f   Fagard, Robert ^g   Yusuf, Salim ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c FUWAI HOSPITAL   (China)

^d INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^e UNIVERSITY OF GUADALAJARA   (Mexico)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

infection; myocardial infarction; prevention; stroke; vaccination

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK REDUCTION; SEASONAL INFLUENZA; STROKE; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; WORLD HEALTH ORGANIZATION;

AGED; BIAS (EPIDEMIOLOGY); DATABASES, FACTUAL; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOPLASMS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEASONS; STROKE;

EID: 84863981710     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.071100     Document Type: Article

References (53)

1. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9:602-610.
2. Sheth T, Nair C, Muller J, Yusuf S. Increased winter mortality from acute myocardial infarction and stroke: the effect of age. J Am Coll Cardiol. 1999;33:1916-1919.
3. Smeeth L, Thomas S, Hall A, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611-2618.
4. Zheng Z, Mittelman M, Tofler G, Pomeroy C, Dampier C, Wides B, Muller J. Infections prior to acute myocardial infarction onset. J Am Coll Cardiol. 1998;31(suppl 1):132-133.
5. Pesonen E, Andsberg E, Grubb A, Rautelin H, Meri S, Persson K, Puolakkainen M, Sarna S, Ohlin H. Elevated infection parameters and infection symptoms predict an acute coronary event. Ther Adv Cardiovasc Dis. 2008;2:419-424.
6. Guan X, Li X, Xin X, Jiang L, Cui L, Wang L, Li H. Influenza virus infection and risk of acute myocardial infarction. Inflammation. 2008;31: 266-272.
7. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 2000;102:3039-3045.
8. Siscovick D, Raghunathan T, Lin D, Weinmann S, Arbogast P, Lemaitre R, Psaty B, Alexander R, Cobb L. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol. 2000;152:674-677.
9. Meyers D, Beahm D, Jurisich P, Milford C, Edlavich S. Influenza and pneumococcal vaccinations fail to prevent myocardial infarction. Heart Drug. 2004;4:96-100.
10. Heffelfinger J, Heckbert S, Psaty B, Weiss N, Thompson W, Bridges C, Jackson L. Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin. 2006;2:161-166.
11. Lavellee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke. 2002;33:513-518.
12. Jackson L, Yu O, Heckbert S, Psaty B, Malais D, Barlow W, Thompson W; Vaccine Safety Datalink Study Group. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol. 2002;156:634-640.
13. Armstrong B, Mangtani P, Fletcher A, Kovats S, McMichael A, Pattenden S, Wilkinson P. Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ. 2004;329:660-663.
14. Wang C, Wang S, Lai C, Lin L, Chou P. Impact of influenza vaccination on major cause-specific mortality. Vaccine. 2007;25:1196-1203.
15. Nichol K, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348:1322-1332.
16. Hung I, Leung A, Chu D, Leung D, Cheung T, Chan C, Lam C, Liu S, Chu C, Ho P, Chan S, Lam T, Liang R, Yuen K. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis. 2010;51:1007-1016.
17. Siriwardena A, Gwini S, Coupland C. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ. 2010;182:1617-1623.
18. Gurfinkel E, de la Fuente R, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study. Eur Heart J. 2004;25:25-31.
19. Ciszewski A, Bilinska Z, Brydak L, Kepka C, Kruk M, Romanowska M, Ksiezycka E, Przyluski J, Piotrowski W, Maczynska R, Ruzyllo W. Influenza vaccination in secondary prevention from coronary ischemic events in coronary artery disease: FLUCAD study. Eur Heart J. 2008; 29:1350-1358.
20. Keller T, Weeds V, van Dongen C, Levi M. Influenza vaccines for preventing coronary heart disease. Cochrane Database Syst Rev. 2008;3: CD005050.
21. Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, Sukonthasarn A. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J. 2011;32:1730-1735.
22. Teo K, Yusuf S, Sleight P, Anderson C, Mookadam F, Ramos B, Hilbrich L, Pogue J, Schumacher H; ONTARGET/TRANSCEND Investigators. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease (ONTARGET/TRANSCENT) trials. Am Heart J. 2004;148: 52-61.
23. ONTARGET Investigators, Yusuf S, Teo K, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547-1559.
24. TRANSCEND Investigators, Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomized controlled trial. Lancet. 2008;372:1174-1183.
25. Mangtani P, Shah A, Roberts J. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect. 2007;135:139-143.
26. World Health Organization Global Health Atlas Data Query. World Health Organization Web site. 2007. http://apps.who.int/globalatlas/DataQuery/default. asp. Accessed on September 20, 2010.
27. Jackson L, Jackson M, Nelson J, Neuzil K, Weiss N. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35:337-344.
28. Jackson L, Nelson J, Benson P, Neuzil K, Reid R, Psaty B, Heckbert S, Larson E, Weiss N. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol. 2006;35:345-352.
29. Ward L, Draper J. A review of the factors involved in older people's decision making with regard to influenza vaccination: a literature review. J Clin Nurs. 2008;17:5-16.
30. Center for Disease Control and Prevention. Update: influenza activity-United States and Worldwide, 2002-2003 season, and composition of the 2003-2004 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2003;52: 516-521.
31. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2003-2004 influenza season. Wkly Epidemiol Rec. 2003;78:58-62.
32. World Health Organization. Addendum to the recommended composition of influenza virus vaccines for use in the 2003-2004 influenza season. Wkly Epidemiol Rec. 2003;78:77-80.
33. Center for Disease Control and Prevention. Update: influenza activity-United States and Worldwide, 2003-2004 season, and composition of the 2004-2005 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2004;53: 547-552.
34. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2004-2005 influenza season. Wkly Epidemiol Rec. 2004;79:88-92.
35. Center for Disease Control and Prevention. Update: influenza activity-United States and Worldwide, 2004-2005 season. MMWR Morb Mortal Wkly Rep. 2005;54:631-634.
36. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2005 influenza season. Wkly Epidemiol Rec. 2004;79:369-373.
37. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season. Wkly Epidemiol Rec. 2005;80:71-76.
38. Center for Disease Control and Prevention. Update: influenza activity-United States and Worldwide, 2005-2006 season, and composition of the 2006-2007 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2006;55: 648-653.
39. Center for Disease Control and Prevention. Update: influenza activity-United States and Worldwide, 2006-2007 season, and composition of the 2007-2008 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2007;56: 789-794.
40. Hanley J, Negassa A, Edwardes M, Forrester J. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol. 2003;157:364-375.
41. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: The Cochrane Collaboration and John Wiley & Sons Ltd; 2008.
42. Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol. 2008;167:492-499.
43. Simonsen L, Viboud C, Taylor R, Miller M, Jackson L. Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine. 2009;27:6300-6304.
44. Lamontagne F, Garant M, Carvalho J, Lanthier L, Smieja M, Pilon D. Pneumococcal vaccination and risk of myocardial infarction. CMAJ. 2008;179:773-777.
45. Tseng H, Slezak J, Quinn V, Sy L, Van den Eeden S, Jacobsen S. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA. 2010;303:1699-1706.
46. Dean A, Moffatt C, Rosewell A, Dwyer D, Lindley R, Booy R, MacIntyre C. Incompletely matched influenza vaccine still provides protection in frail elderly. Vaccine. 2010;28:864-867.
47. Herrera G, Iwane M, Cortese M, Brown C, Gershman K, Shupe A, Averhoff F, Chaves S, Gargiullo P, Bridges C. Influenza vaccine effectiveness among 50-64 year old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, Unites States, 2003-2004. Vaccine. 2007;25:154-160.
48. Nelson J, Jackson M, Wiess N, Jackson J. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol. 2009;62:687-694.
49. Huss A, Scott P, Stuck A, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ. 2009;180:48-58.
50. Moberley S, Holden J, Tatham D, Andrews R. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2008; 23:CD000422.
51. Davis M, Taubert K, Benin A, Brown DW, Mensah G, Baddour L, Dunbar S, Krumholz H; American Heart Association; American College of Cardiology; American Association of Cardiovascular and Pulmonary Rehabilitation; American Association of Critical Care Nurses; American Association of Heart Failure Nurses; American Diabetes Association; Association of Black Cardiologists, Inc; Heart Failure Society of America; Preventive Cardiovascular Nurses Association; American Academy of Nurse Practitioners; Centers for Disease Control and Prevention and the Advisory Committee on Immunization. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol. 2006;48:1498-1502.
52. Gopal S, Davis M. Delivery of influenza vaccine to non-elderly persons with cardiovascular disease with varying national supply of vaccine: a decision analysis. Hum Vaccin. 2005;1:217-223.
53. Jefferson T, Di Pietrantonj C, Al-Ansary L, Ferroni E, Thorning S, Thomas R. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010;2:CD004876.